These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3027640)

  • 1. Studies on the standardization of mistletoe preparations.
    Wagner H; Jordan E; Feil B
    Oncology; 1986; 43 Suppl 1():16-22. PubMed ID: 3027640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
    Jordan E; Wagner H
    Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R; Sandvig K; Olsnes S
    Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum.
    Lee HS; Kim YS; Kim SB; Choi BE; Woo BH; Lee KC
    Cell Mol Life Sci; 1999 Apr; 55(4):679-82. PubMed ID: 10357236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mistletoe lectins and their A and B chains.
    Franz H
    Oncology; 1986; 43 Suppl 1():23-34. PubMed ID: 3543782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of isolated mistletoe lectin chains in plant extracts.
    Tonevitsky AG; Marx U; Agapov I; Moisenovich M
    Arzneimittelforschung; 2002; 52(1):67-71. PubMed ID: 11838276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
    Büssing A; Suzart K; Bergmann J; Pfüller U; Schietzel M; Schweizer K
    Cancer Lett; 1996 Jan; 99(1):59-72. PubMed ID: 8564930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM; Stettin A; Schultze J; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration of colorimetric protein assays for quantitation of plant AB toxins.
    Jiménez M; André S; Gabius HJ; Solís D
    Anal Biochem; 2000 Sep; 284(2):418-20. PubMed ID: 10964431
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of heterogeneity of lectins in mistletoe preparations by monoclonal antibodies to their A-subunits.
    Tonevitsky AG; Agapov I; Temiakov D; Moisenovich M; Maluchenko N; Solopova O; Würzner G; Pfueller U
    Arzneimittelforschung; 1999 Nov; 49(11):970-5. PubMed ID: 10604051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and properties of polysaccharides from Viscum album (L.).
    Jordan E; Wagner H
    Oncology; 1986; 43 Suppl 1():8-15. PubMed ID: 3808577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
    Park JH; Hyun CK; Shin HK
    Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
    Stettin A; Schultze JL; Stechemesser E; Berg PA
    Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
    Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
    FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.